Drug Database
S-

S-amlodipine gentisate (Nexad / Nexad TAb)

✓ Approved

SK Chemicals · CACNA1C · Small Molecule

What is S-amlodipine gentisate?

S-amlodipine gentisate is a small molecule developed by SK Chemicals. It is approved for therapeutic indications via oral (po).

Drug Profile

Brand NamesNexad, Nexad TAb
CompanySK Chemicals
Drug ClassSmall Molecule
Molecular TargetCACNA1C
RouteOral (PO)
StatusApproved
Sources: ClinicalTrials.gov, SK Chemicals

Mechanism of Action

Molecular Targets

S-amlodipine gentisate acts on 1 molecular target:

CACNA1Ccalcium voltage-gated channel subunit alpha1 C (CACNL1A1, CACNA1C-IT2)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

S-amlodipine gentisate is developed for 2 unique indications across 2 therapeutic areas.

Therapeutic AreaConditionPhase
Cardiac disordersAngina pectoris✓ Approved
Vascular disordersHypertension✓ Approved

Related Research Articles

Unable to load articles right now.

Ask about S-amlodipine gentisate